Solid crystal suspensions containing griseofulvin-Preparation and bioavailability testing

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 2, 2013, Pages 193-202

  Reitz, Elena ^a   Vervaet, Chris ^b   Neubert, Reinhard H H ^c   Thommes, Markus ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GHENT UNIVERSITY   (Belgium)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Crystallization; Dispersion; Extrusion; Granulation; Suspension

Indexed keywords

GRISEOFULVIN; DRUG CARRIER; SUSPENSION; TABLET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CRYSTALLIZATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MANUFACTURE; DRUG SOLUBILITY; EXPERIMENTAL DOG; NONHUMAN; PARTICLE SIZE; SOLID CRYSTAL SUSPENSION TECHNOLOGY; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DOG; HEAT; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SOLUBILITY; SUSPENSION; TABLET;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DOGS; DRUG CARRIERS; GRISEOFULVIN; HOT TEMPERATURE; PARTICLE SIZE; SOLUBILITY; SUSPENSIONS; TABLETS;

EID: 84873719471     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.09.012     Document Type: Article

References (39)

1. J.H. Hu, K.P. Johnston, and R.O. Williams Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs Drug Dev. Ind. Pharm. 30 2004 233 245
2. A.H. Yalkowsky Techniques of Solubilisation of Drugs 1981 Marcel Dekker New York
3. S. Janssens, and G. van den Mooter Review: physical chemistry of solid dispersions J. Pharm. Pharmacol. 61 2009 1571 1586
4. C.M. Keck, and R.H. Mueller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16
5. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 23 1997 3 25
6. G.L. Amidon A theoretical basis for a biopharmaceutic drug classification-the correlation of in-vitro drug product dissolution and in-vivo bioavailability Pharm. Res. 12 1995 413 420
7. FDA, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, Guidance for Industry 2000.
8. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60
9. N. Midoux Micronization of pharmaceutical substances in a spiral jet mill Powder Technol. 104 1999 113 120
10. E. Brunner Reaktionsgeschwindigkeit in heterogenen systemen Z. Phys. Chem. 47 1904 56 102
11. W. Nernst Theorie der Reaktionsgeschwindigkeit in heterogenen systemen Z. Phys. Chem. 47 1904 52 55
12. M. Thommes Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions Mol. Pharm. 8 2011 727 735
13. W.L. Chiou, and S. Riegelmann Pharmaceutical applications of solid dispersion systems J. Pharm. Sci. 60 1971 1281 1302
14. N.A. Urbanetz Stabilization of solid dispersions of nimodipine and polyethylene glycol Eur. J. Pharm. Sci. 28 2006 2000 67 76
15. A.T.M. Serajuddin, and C.I. Jarowski Influence of PH on release of phenytoin sodium from slow-release dosage forms J. Pharm. Sci. 82 1993 306 310
16. N. Aoyagi Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans J. Pharm. Sci. 71 1982 1169 1172
17. H. Kamimura, Y. Omi, and Y. Shiobara Simultaneous determination of griseofulvin and 6-desmethylgriseofulvin in plasma by electron-capture gas-chromatography J. Chromatogr. 163 1979 271 279
18. H. Zia Chromatographic analysis of griseofulvin and metabolites in biological-fluids J. Chromatogr. 181 1 1980 77 84
19. P.A. Harris, and S. Riegelma Metabolism of griseofulvin in dogs J. Pharm. Sci. 58 1969 93 96
20. M. Thommes, R. Pinal, M.T. Carvajal, Solid Formulations of Crystalline Compounds, PCT Patent, WO/2009/052391.
21. L. Sachs, and J. Hedderich Textbook-Applied Statistics 2009 Springer Berlin
22. L. Eriksson et al., Design of Experiments Principles and Applications, third revised and enlarged edition, Umetrics, Sweden, 2008.
23. P. Langguth, G. Fricker, and H. Wunderli-Allenspach Textbook-Biopharmazie 2004 Wiley-VCH-Verlag Weinheim
24. R.S. Wagner, B.G. Charles, and J.L. Lach Isolation of 6-demethylgriseofulvin from urine Clin. Chem. 26 1980 363
25. I. Merck Different Monographs, The Merck Index-An Encyclopedia of Chemicals, Drugs and Biological 1989 Merck & Co. Rahway NJ, USA
26. J.M. Breitenbach Melt-extruded molecular dispersions I.M. Ghebre Sellassie, Pharmaceutical Extrusion Technology 2003 Marcel Dekker New York
27. R. Yamamoto, and A. Onuki Dynamics and rheology of a supercooled polymer melt in shear flow J. Chem. Phys. 1 117 2002 2359 2367
28. L. Yu, D.S. Mishra, and D.R. Rigsbee Determination of the glass properties of D-mannitol using sorbitol as an impurity J. Pharm. Sci. 87 1998 774 777
29. A. Dreiblatt Process design I.M. Ghebre Sellassie, Pharmaceutical Extrusion Technology 2003 Marcel Dekker New York 345 359
30. W. Thiele Twin-screw extruder and screw design I.M. Ghebre Sellassie, Pharmaceutical Extrusion Technology 2003 Marcel Dekker New York 69 98
31. L.S. García-Colín, L.F. del Castillo, and P. Goldstein Theoretical basis for the Vodel-Fulcher-Tammann equation Phys. Rev. B 40 1989 7040 7044
32. M. Grassi, and G. Grassi Mathematical modelling and controlled drug delivery: matrix systems Curr. Drug Delivery 2 2005 97 116
33. A. Burger Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol J. Pharm. Sci. 89 2000 457 468
34. JRS-PHARMA, Product Data Sheet: Prosolv HD 90, JRS PHARMA GmbH & Co. KG, 2010.
35. D. Ghanam, I. Hassan, and P. Kleinebudde Compression behaviour of κ-carrageenan pellets Int. J. Pharm. 390 2010 117 127
36. W.A. Ritschel, A. Bauer-Brandl, Die Tablette, Handbuch der Entwicklung, Herstellung und Qualitätssicherung, Editio-Cantor-Verl, Aulendorf, 2002.
37. F. Bracher et al., Arzneibuch Kommentar, Monograph Griseofulvin. Wissenschaftliche Verlagsgesellschaft, Stuttgart, Govi Verlag, Eschborn, 2010.
38. Database "Fachinformation", Monograph Griseo-CT Tabletten, Electronic Release, 2007.
39. EMA, Guideline on the Investigation of Bioequivalence, European Medicines Agency, 2010. < http://www.ema.europe.eu >.